Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.29 USD
−14.65 M USD
3.23 M USD
24.40 M
About IceCure Medical Ltd.
Sector
Industry
CEO
Eyal Shamir
Website
Headquarters
Caesarea
Founded
2006
ISIN
IL0011224156
FIGI
BBG005K17W05
IceCure Medical Ltd. engages in the development and marketing of therapy for the treatment of tumors. Its product, ProSense Cryoablation System, provides invasive treatment option to destroy tumors by freezing them. The company was founded in 2006 and is headquartered in Caesarea, Israel.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ICCM is 1.12 USD — it has decreased by −0.87% in the past 24 hours. Watch IceCure Medical Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IceCure Medical Ltd. stocks are traded under the ticker ICCM.
ICCM stock has risen by 16.01% compared to the previous week, the month change is a 90.00% rise, over the last year IceCure Medical Ltd. has showed a 21.74% increase.
We've gathered analysts' opinions on IceCure Medical Ltd. future price: according to them, ICCM price has a max estimate of 4.60 USD and a min estimate of 2.50 USD. Watch ICCM chart and read a more detailed IceCure Medical Ltd. stock forecast: see what analysts think of IceCure Medical Ltd. and suggest that you do with its stocks.
ICCM reached its all-time high on Aug 26, 2021 with the price of 12.40 USD, and its all-time low was 0.02 USD and was reached on Dec 10, 2020. View more price dynamics on ICCM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ICCM stock is 7.21% volatile and has beta coefficient of −1.05. Track IceCure Medical Ltd. stock price on the chart and check out the list of the most volatile stocks — is IceCure Medical Ltd. there?
Today IceCure Medical Ltd. has the market capitalization of 61.35 M, it has increased by 29.34% over the last week.
Yes, you can track IceCure Medical Ltd. financials in yearly and quarterly reports right on TradingView.
IceCure Medical Ltd. is going to release the next earnings report on Feb 3, 2025. Keep track of upcoming events with our Earnings Calendar.
ICCM earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.07 USD resulting in a −6.67% surprise. The estimated earnings for the next quarter are −0.07 USD per share. See more details about IceCure Medical Ltd. earnings.
IceCure Medical Ltd. revenue for the last quarter amounts to 662.00 K USD, despite the estimated figure of 708.50 K USD. In the next quarter, revenue is expected to reach 1.07 M USD.
ICCM net income for the last quarter is −4.15 M USD, while the quarter before that showed −3.08 M USD of net income which accounts for −34.66% change. Track more IceCure Medical Ltd. financial stats to get the full picture.
No, ICCM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 77.00 employees. See our rating of the largest employees — is IceCure Medical Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IceCure Medical Ltd. EBITDA is −14.25 M USD, and current EBITDA margin is −472.38%. See more stats in IceCure Medical Ltd. financial statements.
Like other stocks, ICCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IceCure Medical Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IceCure Medical Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IceCure Medical Ltd. stock shows the buy signal. See more of IceCure Medical Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.